News, Analysis & Insights on Nutrition, Supplements, and Health
News in brief
Bayer has announced the completion of its investment in Care/of, giving it a majority ownership in the personalized nutrition player. The deal deepens Bayer’s capabilities in the personalized healthcare and nutritionals space.
Probiota Champions: In conversation with Jarrow Rogovin
“Dietary supplements are American folk medicine, and it’s a fascinating one because it involves a lot of good science… and – very importantly – we have a regulatory framework, DSHEA, that’s rational,” Jarrow Rogovin told NutraIngredients-USA recently.
Culturelle recently entered into the gummy market with the release of adult and kids probiotic gummies.
Industry stakeholders anticipated a smooth working relationship with a new Biden Administration, but said this year’s highly unusual circumstances makes this transition more uncertain than most.
Bioenergy Life Sciences has taken the route of developing more complete product prototype ideas for its ingredients as a way to better reach potential customers in this era of no face-to-face events.
Supplementing statin-treated patients with omega-3, as a adjunct therapy, does not reduce their chances of suffering major adverse cardiovascular events, according to a new study which was terminated early due to the lack of positive results.